2011 annual financial data
Halozyme Therapeutics 2011 Operating margin
Halozyme Therapeutics 2011 operating margin with verified reported values.
Direct answer
Operating margin was -35.37%.
Operating income was -19,838,941 USD and net income was -19,769,851 USD.
Operating cash flow was -34,350,425 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 56,086,436 USD
- Operating income
- -19,838,941 USD
- Net income
- -19,769,851 USD
- Operating cash flow
- -34,350,425 USD